Efficacy and Safety of Once-Weekly Insulin Icodec vs. Once-Daily Basal Insulin in Type 2 Diabetes according to Baseline Glucagon-Like Peptide 1 Receptor Agonist Use-ONWARDS 1-5

Tina Vilsboll; Katrine O. Bangsgaard; Ariel Fu; Monika Kellerer; Stinne B. Sogaard; Ronald Goldenberg

doi:10.2337/db24-840-P

Efficacy and Safety of Once-Weekly Insulin Icodec vs. Once-Daily Basal Insulin in Type 2 Diabetes according to Baseline Glucagon-Like Peptide 1 Receptor Agonist Use-ONWARDS 1-5

Tina Vilsboll, Katrine O. Bangsgaard, Ariel Fu, Monika Kellerer, Stinne B. Sogaard, Ronald Goldenberg

Steno Diabetes Center Copenhagen

Original language	English
Journal	Diabetes
Volume	73
Issue number	1
ISSN	0012-1797
DOIs	https://doi.org/10.2337/db24-840-P
Publication status	Published - 1 Jun 2024
Event	American Diabetes Association’s 84th Scientific Sessions, ADA - Orange County Convention Center, Orlando, United States Duration: 21 Jun 2024 → 24 Jun 2024 https://professional.diabetes.org/scientific-sessions

Conference

Conference	American Diabetes Association’s 84th Scientific Sessions, ADA
Location	Orange County Convention Center
Country/Territory	United States
City	Orlando
Period	21/06/2024 → 24/06/2024
Internet address	https://professional.diabetes.org/scientific-sessions

Access to Document

10.2337/db24-840-P

Cite this

Efficacy and Safety of Once-Weekly Insulin Icodec vs. Once-Daily Basal Insulin in Type 2 Diabetes according to Baseline Glucagon-Like Peptide 1 Receptor Agonist Use-ONWARDS 1-5. / Vilsboll, Tina; Bangsgaard, Katrine O.; Fu, Ariel et al.
In: Diabetes, Vol. 73, No. 1, 01.06.2024.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

@article{616067df259c4307a24401714ab856cb,

title = "Efficacy and Safety of Once-Weekly Insulin Icodec vs. Once-Daily Basal Insulin in Type 2 Diabetes according to Baseline Glucagon-Like Peptide 1 Receptor Agonist Use-ONWARDS 1-5",

author = "Tina Vilsboll and Bangsgaard, \{Katrine O.\} and Ariel Fu and Monika Kellerer and Sogaard, \{Stinne B.\} and Ronald Goldenberg",

note = "84th Annual Scientific Meeting of American-Diabetes-Association (AMA), Orlando, FL, JUN 21-24, 2024; American Diabetes Association{\textquoteright}s 84th Scientific Sessions, ADA, ADA ; Conference date: 21-06-2024 Through 24-06-2024",

year = "2024",

month = jun,

day = "1",

doi = "10.2337/db24-840-P",

language = "English",

volume = "73",

journal = "Diabetes",

issn = "0012-1797",

publisher = "American Diabetes Association",

number = "1",

url = "https://professional.diabetes.org/scientific-sessions",

}

TY - ABST

T1 - Efficacy and Safety of Once-Weekly Insulin Icodec vs. Once-Daily Basal Insulin in Type 2 Diabetes according to Baseline Glucagon-Like Peptide 1 Receptor Agonist Use-ONWARDS 1-5

AU - Vilsboll, Tina

AU - Bangsgaard, Katrine O.

AU - Fu, Ariel

AU - Kellerer, Monika

AU - Sogaard, Stinne B.

AU - Goldenberg, Ronald

N1 - 84th Annual Scientific Meeting of American-Diabetes-Association (AMA), Orlando, FL, JUN 21-24, 2024

PY - 2024/6/1

Y1 - 2024/6/1

U2 - 10.2337/db24-840-P

DO - 10.2337/db24-840-P

M3 - Conference abstract in journal

SN - 0012-1797

VL - 73

JO - Diabetes

JF - Diabetes

IS - 1

T2 - American Diabetes Association’s 84th Scientific Sessions, ADA

Y2 - 21 June 2024 through 24 June 2024

ER -